NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy

por Rothan, Hussin A., Amini, Elham, Faraj, Fadihl L., Golpich, Mojtaba, Teoh, Teow Chong, Gholami, Khadijeh, Yusof, Rohana
Publicado 2017